Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 18 Neoplasms 9 Colonic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 6 Uterine Cervical Neoplasms 4 Colorectal Neoplasms 4 Uterine Cervical Dysplasia 3 Urinary Bladder Neoplasms 3 Mouth Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Thyroid Nodule 2 Thyroid Neoplasms 2 Thrombocythemia, Essential 2 Testicular Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Oropharyngeal Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Liver Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Hodgkin Disease 2 Glioma 2 Gallbladder Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Basal Cell 2

Interventions

Cyclophosphamide 297 Rituximab 272 Etoposide 149 Filgrastim 142 fludarabine phosphate 120 Cytarabine 109 Vincristine 107 Melphalan 102 Radiotherapy 101 Doxorubicin 97 Peripheral Blood Stem Cell Transplantation 93 Methotrexate 91 fludarabine 86 Prednisone 86 Busulfan 86 Tacrolimus 66 Mycophenolic Acid 62 Granulocyte Colony-Stimulating Factor 60 Antilymphocyte Serum 58 Dexamethasone 57 Whole-Body Irradiation 55 Carmustine 54 Bortezomib 45 Cyclosporine 44 Lenalidomide 41 Methylprednisolone 40 sargramostim 39 Bendamustine Hydrochloride 37 ibritumomab tiuxetan 34 Ifosfamide 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma × Watchful Waiting × Clear all

NCT01088750 2023-12-13

EuroNetLP1

Martin-Luther-Universität Halle-Wittenberg

Phase 4 Completed

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡